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The peptides orexin A (OxA) and orexin B (OxB) deriving from a common precursor molecule, prepro-
orexin, by proteolytic cleavage, bind the two G-coupled OX1 and OX2 receptors. While OX1 selectively
binds OxA, OX2 shows similar affinity for both orexins. Firstly discovered in the hypothalamus, orexins
and their receptors have been found in other brain regions as well as in peripheral tissues of mammals,
thus resulting involved in the regulation of a broad variety of physiological functions. While the
functional localization of OxA and OX1 in the mammalian genital tract has been already described, the
expression of OxB and OX2 and their potential role in the reproductive functions remain to be explored.
Here, we investigated the presence of OxB and OX2 in the rat testis by immunohistochemical and
biochemical analyses. The results definitely demonstrated the localization of OxB and OX2 in pachytene
and second spermatocytes as well as in spermatids at all stages of the cycle of the seminiferous epithe-
lium. The expression of both OX2 mRNA and protein in the rat testis was also established by RT-PCR and
Western blotting, respectively. The analysis of the molecular mechanism of action of OxB in the rat testis
showed that OxB, in contrast with OxA, is unable to promote steroidogenesis. These results translate into
the regulation of diverse biological actions by OxA and OxB in the male gonad.
 2015 Elsevier Inc. All rights reserved.1. Introduction
At the end of the last century, two independent research groups
discovered in the rat hypothalamus two novel peptides called
hypocretins/orexins, namely orexin A (OxA) and orexin B (OxB)
(de Lecea et al., 1998; Sakurai et al., 1998). Both neuropeptides
derive from a common 130 amino acid precursor molecule,
prepro-orexin, by proteolytic cleavage. Orexins bind two
G-coupled membrane receptors: OX1 which selectively binds
OxA, and OX2 which shows similar affinity for both orexins. In gen-
eral, OX1 is thought to couple to Gq, and OX2 can signal through Gq
or Gi/Go, but coupling mechanisms seem to differ by cell type
(Randeva et al., 2001; Karteris and Randeva, 2003). Both receptors
are strongly conserved across mammals, with rat OX1 and OX2 dis-
playing 94% and 95% sequence homology, respectively, with
human receptors (Sakurai et al., 1998).
In the central nervous system, the cell bodies producing orexins
are localized in a narrow zone within the lateral hypothalamus andproject mainly to brain regions involved in the regulation of feed-
ing, sleep, neuroendocrine homeostasis, and autonomic functions
(Kukkonen et al., 2002; Ohno and Sakurai, 2008; Nixon et al.,
2015). Orexins and their receptors are also found outside the cen-
tral nervous system, e.g., in the gastrointestinal tract, pancreas,
cardiovascular system, adrenal glands, and reproductive apparatus,
where they orchestrate multifaceted physiological functions
(Shahid et al., 2012; Kukkonen, 2013; Li et al., 2014). The ablation
of orexin receptors or an impairment of their signaling leads to
narcolepsy phenotypes in animal models (Chemelli et al., 1999;
Lin et al., 1999; Thannickal et al., 2000). However, many other
human pathological conditions have been correlated to the orexin
system dysfunctions, including drug addiction, alcohol-seeking
behaviour, anxiety/panic states, and cardiovascular, metabolic
and inflammatory diseases (Matsuki and Sakurai, 2008;
Szczepanska-Sadowska et al., 2010; Xu et al., 2013).
In recent years, much research efforts have been focused to
investigate the expression and the physiological role of orexins in
the mammalian genital tract. We previously demonstrated the
expression of OxA, prepro-orexin and OX1 in the principal cells of
the epididymis and testis of rat and alpaca (Tafuri et al., 2009,
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prostatic complex and the vestibular glands of cattle (Russo et al.,
2008; Pavone et al., 2009), and in the human normal and hyper-
plastic prostate (Valiante et al., 2013). Expression of OX1 mRNA
has also been found in the sheep testis (Zhang et al., 2005) and
in the human seminal vesicles, penis and epididymis (Karteris
et al., 2004). By contrast, only few reports describe the presence
of OxB and OX2 in the male reproductive system of mammals.
The peptide OxB was detected in the rat testis by a radio-
immuno assay (Mitsuma et al., 2000), and the presence of
prepro-orexin and OX2 mRNAs was demonstrated in the human
testis, epididymis, penis, seminal vesicles (Karteris et al., 2004)
and prostate (Malendowicz et al., 2011). However, other investiga-
tions failed to detect OX2 mRNA expression in sheep (Zhang et al.,
2005) and rat testis (Jöhren et al., 2001; Barreiro et al., 2004; Zheng
et al., 2014).
Overall, these findings raise the possibility of additional
peripheral actions of orexins and their receptors in the control of
reproductive function, in addition to their role as central neuroen-
docrine modulators of the reproductive axis (Nurmio et al., 2010).
Indeed, an action of OxA in the control of testicular steroidogenesis
in rats was demonstrated (Barreiro et al., 2004, 2005; Assisi et al.,
2012; Zheng et al., 2014). However, the expression of OxB and OX2
in the male gonads and the elucidation of their potential role in the
reproductive functions is still an open issue. In this study, the local-
ization of OxB and OX2 in the rat testis was investigated by
immunohistochemistry. Biochemical analyses such as RT-PCR and
Western blotting were carried out to establish the presence of
OX2 at molecular level in the tissue. Furthermore, in order to get
insights into the potential role of OxB in the gonad, its ability to
stimulate steroidogenesis was also evaluated.2. Material and methods
2.1. Antibodies and chemicals
Mouse anti-OxA (MAB763) and anti-OxB (MAB734) monoclonal
antibodies were obtained from R&D Systems (Abingdon, UK) and
their synthetic peptides from Tocris Bioscience (Bristol, UK); rabbit
polyclonal anti-OX2 antibody (ab3094), its blocking peptide
(AG794) from Millipore (Billerica, Massachusetts, USA); horserad-
ish peroxidase conjugated anti-rabbit IgG (A-0545) from Sigma
Chemical Co. (St. Louis, MO, USA); biotinylated goat anti-mouse
(BA-9200) and goat anti-rabbit (BA-1000) secondary antibodies
and avidin–biotin complex (PK-6105) from Vector Laboratories
(Burlingame, CA, USA). The peptide OxB (003-32) was purchased
from Phoenix Pharmaceuticals Inc. (Karlsruhe, Germany), the
luteinizing hormone (LH) from sheep pituitary (L5269), and bovine
serum albumin (BSA) from Sigma Chemical Co.; the enhanced
chemiluminescence (ECL) kit, the GFX PCR DNA and gel purifica-
tion kit from Amersham (Little Chalfont, UK); the DC protein assay
kit from Bio-Rad Laboratories (Hercules, CA, USA). The primers
were provided by Primm (Milan, Italy), and the kit for PCR and
RT-PCR by Promega (Madison, WI, USA); EIA kit for testosterone
determination from Adaltis (Bologna, Italy).2.2. Animals
Twelve healthy adult Wistar male rats obtained from Charles
River (Calco, Lecco, Italy) were bred in the vivarium of the Depart-
ment of Veterinary Medicine and Animal Productions at the
University of Naples Federico II (Naples, Italy). The animals were
kept in groups of two rats for cage with free access to food and
tap water, under constant conditions of light and temperature
(22 C). The experimental procedures were approved by the EthicalCommittee for Animal Experimentation of our University, and
were conducted in accordance with the European Union normative
for care and use of experimental animals. The anesthetized animals
were killed by decapitation, and their testes collected soon after
death. Samples from twelve testes of different animals were fixed
in Bouin fluid for 24–48 h, and processed for immunohistochem-
istry. Fragments from other testes were frozen in liquid nitrogen,
and stored at 80 C until used for biochemical analyses.
2.3. Immunohistochemistry
The Bouin-fixed samples were dehydrated in ascending
alcohols, embedded in Paraplast, and cut in 6 lm thick sections
by microtome. In order to obtain consecutive stained microscopic
fields, series of 3 lm thick sections were carefully cut and mounted
on numbered slides. Mouse monoclonal anti-OxA and anti-OxB
and rabbit polyclonal anti-OX2 primary antibodies diluted 1:200
were applied on sections, and incubated overnight at 6 C. Before
staining, some sections were dipped in a citrate buffer, pH 6.0,
and heated in a microwave oven for 10 min at 750 W to reveal
masked antigens. Then, sections were incubated with biotinylated
goat anti-mouse and goat anti-rabbit secondary antibodies for
30 min. The 3-30 diaminobenzidine (DAB) was used as final stain-
ing. Some sections were counterstained with hematoxylin in order
to better localize the immunoreactive structures and identify the
stage of germ epithelium developing cycle according to the proce-
dure described by Clermont and Perey (1957). The preparations
were visualized by a Nikon Eclipse E 600 light microscope, and
photographed by a Nikon Colpix 8400 digital camera.
In order to verify the manufacturer statement that the two anti-
bodies directed against OxA and OxB do not cross react with the
heterologous antigen, each antibody was pre-absorbed with the
heterologous peptide before staining. In both cases, the positivity
resulted to be unaffected (data not shown). Moreover, the anti-
OxA and anti-OxB antibody were alternately applied on 3 lm thick
consecutive sections, and couples of adjacent sections were care-
fully observed to study the tissue distribution of the two immunos-
tainings. Indeed, their potential coexistence would indicate an
improper antibody/antigen reaction.
2.4. RNA extraction and RT-PCR analysis
Total RNA was extracted from rat testis samples by using Trizol
solution, re-suspended in 50 ll diethyl pyrocarbonate treated
water, and stored at 80 C until used. Synthesis of cDNAs for
OX2 detection was performed by using the Promega reverse-
transcription (RT) system. The following specific primers were
used: 50-TGTCCAGCACCAAATTGGAG-30 (forward) and 50-ACCATC
GGTCCAAGGCAATG-30 (reverse). These primers were designed in
such a way that forward and reverse ones span different exons,
so that the amplification product obtained from the cDNA would
be of different length to that obtained from any contaminant geno-
mic DNA comprising intronic sequences. To definitely rule out the
possibility of amplifying genomic DNA, one PCR was carried out
prior to RT of the RNA. As internal control for RT and reaction effi-
ciency, amplification of rat b-actin mRNA was carried out in each
sample using the primer: 50-GAGGCTCAGAGCAAGAGAGG-30 (for-
ward) and 50-TGACATCTCGCACAATCTCC-30 (reverse). As a negative
control distilled water was used. All PCRs were carried out using
Taq DNA polymerase (Life Technologies, Inc., Monza, Italy) with
200 ng cDNA for each amplification. Each of 30 cycles of amplifica-
tion consisted of a denaturing phase of 1 min at 94 C, annealing
phase of 30 s at 65 C, and an extension of 1 min at 72 C. Amplified
PCR products were separated on a 2% agarose gel, and visualized by
ethidium bromide using a 1 kb DNA ladder to estimate the band
sizes. The bands were cut off from the gel, purified using
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by Primm (GenBank accession numbers: NM_013074 for rat OX2;
NM_031144 for rat b-actin).
2.5. Western blotting
Testis samples were homogenized by an Ultraturrax L-407 at
4 C with 5 ml/1.5 g tissue of buffer containing 50 mM Tris–HCl
(pH 7.4), 150 mM NaCl, 1 mM EDTA, 10 mM NaF, 0.5 g/100 ml
deoxycholic acid, 0.1 g/100 ml sodium dodecyl sulfate (SDS), 1%
(v/v) Nonidet P-40, 1 mM phenylmethyl-sulfonyl fluoride, 10 lg/
ml aprotinin, 10 lg/ml leupeptin, and 1 mM Na3VO4. Homogenates
were centrifuged at 15,000g for 10 min at 4 C. The total amount
of proteins in the obtained supernatant was determined by the Bio-
Rad DC protein assay. Samples containing equal amount of pro-
teins (100 lg) were boiled for 5 min in SDS buffer (50 mM Tris–
HCl pH 6.8, 2% SDS, 10% glycerol, 0.1% bromophenol blue and 5%
b-mercaptoethanol), run on a 12.5% SDS/polyacrylamide gel, and
transferred to nitrocellulose using a Mini trans-blot apparatus
(Bio-Rad Laboratories). Membranes were blocked for 1 h at room
temperature with TBS-T buffer (150 mM NaCl, 20 mM Tris HCl
pH 7.4, 0.1% Tween 20) containing 5% milk. The blots were incu-
bated overnight with the anti-OX2 antibody diluted 1:1000 in
TBS-T containing 2.5% milk. After the incubation, the membranes
were washed three times with TBS-T, and incubated for 1 h with
horseradish peroxidase conjugated anti-rabbit IgG diluted 1:3000
in TBS-T containing 2.5% milk. The proteins were visualized by
ECL. To monitor loading of gel lanes, the blot was stripped by incu-
bation for 30 min at 70 C with a solution containing 2% SDS,
100 lM b-mercaptoethanol in 62.5 mM Tris–HCl, pH 6.8, and re-
probed using anti-c-tubulin monoclonal antibody.
2.6. Evaluation of testicular production of testosterone
The removed testes were decapsulated and cut into pieces of
approximately equal size (mean weight/piece: 250 ± 7 mg). Testic-
ular slices (2 slices/well) were kept in 2 ml of Krebs–Ringer bicar-
bonate buffer (KRB), pH 7.4, containing 10 mM glucose, 100 lM
bacitracin, 0.1% ascorbic acid, and 0.1% BSA, for 60 min at 37 C
in an atmosphere of 95% O2 and 5% CO2, with constant shaking at
60 cycles/min. Then, the medium was substituted with 2 ml of
fresh KRB buffer containing increasing concentrations (109–
106 M) of OxB, and the samples were incubated for further 12 h.
Negative controls were treated with medium alone, while positive
controls were obtained by incubating testis slices for 12 h with LH
(500 ng/g tissue) or OxA (1 nM) (Barreiro et al., 2005; Liguori et al.,
2012). At the end of the incubation, the mediumwas aspirated, and
divided in aliquots which were processed to assess testosterone
levels. To this purpose, the medium was vigorously mixed with
ethyl ether (1:10, v/v) and the ether phase was withdrawn after
centrifugation at 3000g for 10 min. Three extractions were per-
formed. Pooled ether extracts were dried by evaporation, and the
residue was dissolved in a 0.5 ml sodium phosphate buffer
0.05 M (pH 7.5) containing BSA at a concentration of 10 mg/ml.
Such solutions were utilized for testosterone immunoassay, as pre-
viously described (Liguori et al., 2012). The following limits of
testosterone detection were obtained: sensitivity 6 pg, intra-
assay variability 5.3%, inter-assay variability 7.5%. The rate of
testosterone recovery from testis samples was about 80%. The
results were expressed as normalized values /g incubated tissue.
2.7. Statistical analysis
Data obtained from in vitro assays were compared by analysis of
variance followed by Duncan’s test for multi-group comparison and
Student’s t-test for between-group comparison. The experimentswere performed in triplicate and data were expressed as
means ± S.D. (standard deviation). The level of significance was
taken at p < 0.01 and p < 0.05.3. Results and discussion
3.1. Immunohistochemical detection of OxB and OX2 in rat testis
The localization of OxB and OX2 receptor in the rat testis was
firstly investigated by immunohistochemistry. The analysis of the
tissue samples showed the presence of OxB-immunoreactivity
(IR) in pachytene spermatocytes (Fig. 1a) and in spermatids under
progressive maturation, i.e., in young (round) (Fig. 1b), intermedi-
ate (oval) (Fig. 1c), and mature (elongated) (Fig. 1d) cells. In the
spermatocytes, OxB-IR had always the shape of a unique, round
and compact cluster of granules localized in the inner portion of
the cytoplasm close to the nuclear membrane. In the round sper-
matids, OxB-IR was found in the perinuclear area appearing as a
weakly stained punctiform granule. During the cell development,
such granule enlarged, became more deeply stained and, loosing
contact with the nuclear membrane, moved towards the caudal
portion of the cell which progressively shaped oval and, finally,
elongated. In mature spermatids, OxB-IR sometimes can acquire
also the aspect of a diffused halo contained within the thin tail of
the cell (Fig. 2c). Cells showing OxB-IR were found in the second
portion of the cycle of the seminiferous epithelium from the VIIth
up to the XIVth stage (Fig. 1e).
The use of series of 3 lm thick sections alternately stained by
anti-OxB and anti-OxA antibodies demonstrated that OxB-
containing cells never contained OxA in our preparations
(Fig. 2a and b). On the other hand, control experiments carried
out pre-absorbing anti-OxB or anti-OX2 antibody with an excess
(100 lg/ml) of their corresponding antigens, always resulted to
be negative (Fig. 2c and d). Leydig cells clearly showing OxA
labeled material (Fig. 2e) were chosen as positive control of the rel-
ative antibody (Barreiro et al., 2005; Liguori et al., 2012).
OX2-IR was found in pachytene (Fig. 3a) and second spermato-
cytes (Fig. 3b), and round (Fig. 3c), oval (Fig. 3d) and elongated
(Fig. 3e) spermatids. The positive structures contained in the first
two cell types closely resembled those described above in pachy-
tene spermatocytes. OX2-IR appeared as a small granule closely
adherent to the nuclear membrane in young spermatids belonging
to the IIth–Vth stage interval of the cycle of the seminiferous
epithelium, and progressively became a semilunar, elongated
structure encircling portion of the nucleus in round/oval sper-
matids belonging to the VIth–IXth stage interval. From the Xth
stage onwards, the positive material had a granular shape, lost con-
tacts with the nucleus and was contained in the middle or terminal
portion of the progressively elongating cell. OX2-IR-containing cell
types were present along the whole cycle of the seminiferous
epithelium (Fig. 3f).
These results provide the first immunohistochemical localiza-
tion of OxB in the male genital tract of mammals. They also
demonstrate the presence of OX2 in rat testis in line with a previ-
ous study showing the localization of OX2 in human testis (Karteris
et al., 2004).3.2. Expression of OX2 mRNA and the protein in rat testis
The presence of OxB in the rat testis is supported by previous
findings showing the expression of the OxB precursor molecule
prepro-orexin in this tissue (Jöhren et al., 2001; Tafuri et al.,
2010). By contrast, OX2 mRNA and the protein expression was
never demonstrated before. Thus, in order to confirm the immuno-
histochemical localization of OX2 observed in rat testis, we
Fig. 1. OxB-immunoreactivity in cytotypes of the rat testis. (a) A round cluster of reactive material is contained in the perinuclear cytoplasm of some pachytene
spermatocytes. (b)–(d) Differently sized and round shaped positive material is present in the cytoplasm of round (b), oval (c) and elongated (d) spermatids whose stage of
development is clearly shown by the progressive elongation of their nuclei. In (c) and (d) positive granules are visible in the intermediate/terminal portion of the cytoplasm of
transversely cut cells. Arrows point two longitudinally cut cells showing both nucleus and positivity in the same plane. The inserts in (a) and (b) show higher magnifications
of a pachytene spermatocyte and a round spermatid contained in the respective microphotographs. A round shaped labeled structure is present in the adluminal portion of
the cytoplasm of both cells. (e) OxB-immunoreactive cytotypes are present in the second half (from the VIIth to XIVth stages) of the cycle of the seminiferous epithelium.
Avidin–biotin immunohistochemical staining. Bars: 20 lm.
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Fig. 2. Anti-OxB and anti-OxA antibodies specificity and controls. (a) and (b) A couple of 3 lm thick consecutive sections has been stained by anti-OxB (a) and anti-OxA (b)
antibodies. OxB-immunoreactive material is present in elongated spermatids (a), whereas no trace of staining is visible in the consecutive section (b). (c) and (d) Negative
controls of the specificity of the antibodies directed against OxB and OX2 were obtained absorbing the antibodies with an excess of the relative antigens. The two
immunological complexes were used to stain the sections reported in (c) and in (d), respectively. No staining is visible in these sections. (e) Leydig cells showing OxA-
containing fine granular material have been chosen as a positive control of the relative antibody functionality. Avidin–biotin immunohistochemical method. Bars: 20 lm.
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protein levels. The expression of mRNA coding for OX2 was ana-
lyzed by RT-PCR and such analysis resulted in the amplification
of specific DNA fragments of 459 bp (Fig. 4A, lane 2). A 469 bp tran-
script was obtained from the amplification of b-actin cDNA in
tested samples (Fig. 4A bottom, lane 2). No amplification products
were obtained when distilled water was used in place of cDNA
(negative control) (Fig. 4A, lane 3).
The presence of OX2 protein in the rat testis was confirmed by
Western blotting, using a rabbit polyclonal antibody raised against
a 19 aminoacid sequence mapping near the C-terminus of OX2 of
rat origin. The detected OX2 protein showed the expected molecu-
lar mass of approximately 40 kDa (Fig. 4B, lane 1) (Randeva et al.,
2001; Karteris et al., 2004; Dehan et al., 2013). The specificity of
the response was confirmed by the pre-incubation of the OX2
antibody with its respective blocking peptide. There was noexpression of OX2 in these preparations (Fig. 4B, lane 2). The
stripping of the upper blot and its re-probing with a monoclonal
anti-c-tubulin antibody demonstrated equal loading of proteins
in all lanes (Fig. 4B, bottom).
These results together with the immunohistochemical localiza-
tion definitely demonstrate the expression of OX2 in the rat testis.
The discrepancy between our findings and the results of previous
studies (Jöhren et al., 2001; Barreiro et al., 2004; Zheng et al.,
2014) can be ascribed to two main factors: (1) the use of different
methodological experimental conditions, including tissue sam-
pling, primers and running cycles selected for RT-PCR, primary
antibody specificity, etc.; (2) the high turnover of cellular produc-
tion and/or internalization of neuroendocrine substances such
orexins and their receptors. Indeed, opposing results are reported
on the localization of orexins and their receptors in other periph-
eral organs such as the adrenal glands (Karteris et al., 2001;
Fig. 3. OX2-immunoreactivity in cytotypes of the rat testis. (a) and (b) In pachytene (a) and second (b) spermatocytes, the immunoreactive material is shaped as a round
granule close in contact with the nuclear membrane and often localized (a) in proximity of the adluminal portion of the cell nuclei. (c)–(e) Along the development of the
spermatids the positive material progressively changes in shape and localization. It is punctiform in aspect in young cells (c), encircles the nucleus of older elements as a
semilunar structure (d) and becomes a coarse, round granule contained in the adluminal cytoplasm of elongated spermatids (e). Arrow (e) points a longitudinally cut
spermatid showing both nucleus and positivity in the same plane. The inserts in (a), (b) and (c) show higher magnifications of a pachytene spermatocyte, a second
spermatocyte and a round spermatid contained in the respective microphotographs. The three cells show in perinuclear position a single, round shaped structure resulting
from the close packaging of stained microgranules. (f) OX2-containing cytotypes are clearly seen along the whole cycle of the seminiferous epithelium. Avidin–biotin
immunohistochemical method. Bars: 25 lm.
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Ziolkowska et al., 2005).
3.3. OxB is unable to affect testosterone secretion in rat testis
The expression of functional orexin receptors in the human
Leydig cells has suggested a potential role for the orexins in
steroidogenesis (Karteris et al., 2004). Indeed, our and other groups
demonstrated that OxA binding to OX1 receptor stimulatestestosterone production in the mammalian testis, probably coun-
teracting the anti-steroidogenic effect of Müllerian inhibiting sub-
stance (Barreiro et al., 2005; Assisi et al., 2012; Liguori et al., 2012).
Furthermore, orexins have been shown to stimulate corticosterone
and cortisol production from dispersed rat and human adrenocor-
tical cells through activation of the adenylate cyclase-dependent
signaling cascade (Malendowicz et al., 1999). In this study, we
tested the ability of OxB to regulate testicular androgenesis
in vitro. Testis slices were absorbed with increasing concentrations
Fig. 4. (A and B) Expression of OX2 mRNA and the protein in the rat testis
homogenates. (A) RT-PCR analysis. Lane 1, DNA ladder; lane 2, OX2 mRNA
transcripts in rat testis sample, lane 3, negative control (no cDNA input). The
bottom reports the b-actin mRNA transcripts in the samples (internal control). (B)
Western blotting analysis. Lane 1, homogenate from rat testis tissue; lane 2 testis
homogenate treated with the antisera directed against OX2 pre-absorbed with its
respective control peptide (negative control). The blots were stripped and re-
probed with an anti-c-tubulin monoclonal antibody to ensure equal loading of
proteins in all lanes (lower blot). Molecular mass markers are indicated on the left.
Similar results of those reported in (A) and (B) were obtained from four separate
experiments of identical design. (C) Effect of OxB on testosterone secretion. Freshly
collected rat testis slices were treated with increasing concentrations (from 109 to
106 M) of OxB, or 1 nM OxA or LH (500 ng/g tissue), and incubated for 12 h. Control
tissue (CTR) was treated with PBS. Testosterone levels are expressed as ng/ml of
tissue extract. The data reported represent the mean ± S.D. of three different
determinations performed in duplicate. *p < 0.05 and **p < 0.01, versus control.
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time was measured. Some other tissue slices were incubated with
OxA (1 nM) or LH (500 ng/g tissue). While OxA significantly
enhanced testosterone production, OxB at all tested concentrations
didn’t show any effect on testosterone synthesis as compared to
control (Fig. 4C). On the other hand, the steroidogenic effect of
12 h long lasting absorption of LH demonstrated that the respon-
siveness of the tissue used in our in vitro settings is warranted.
These results are consistent with previous findings showing that
OxA is able to enhance glucocorticoid secretion in rat and human
adrenal cortices, while OxB was found to be either less potent or
ineffective (Kagerer and Jöhren, 2010). Although further studies
are needed to fully establish the activity of OxB in the mammalian
testis, our results demonstrate that, in contrast with the definite
evidence that OxA induces steroidogenesis in the rat testis
(Barreiro et al., 2005; Assisi et al., 2012; Zheng et al., 2014), the role
of OxB does not imply a direct involvement in the testicular
steroidogenesis.4. Conclusions
This study provides the first evidence for the localization of OxB
and OX2 receptor in the rat pachytene and second spermatocytes
and spermatids at all stages of the cycle of the seminiferousepithelium. We also demonstrate the expression of both OX2
mRNA and the protein in the rat testis, while the presence of
OxB in the tissue is supported by the detection of prepro-orexin
previously demonstrated by us and other authors (Jöhren et al.,
2001; Tafuri et al., 2010). The analysis of the mechanism of action
of OxB in the rat testis shows the inability of the peptide in
promoting steroidogenesis. These results likely translate into the
regulation of diverse biological actions by the two orexins and
their receptors in the male gonad.
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